Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin-12: clinical usage and molecular markers of cancer susceptibility.

Growth factors (Chur, Switzerland) - 1 Jun 2012

Yuzhalin Arseniy E, Kutikhin Anton G

Abstract excerpt

The last decade has seen the emergence of immunomodulators as therapeutic agents in cancer treatment. Interleukins (ILs) are a category of small cell-signaling molecules that organize communication and interaction between immune cells and therefore they could be used as perfect immunomodulators. IL-12 is a promising candidate for cancer immunotherapy since it plays a major role in development of antitumor immune...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Genetic Predisposition to Disease
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-12

Share to Interleukin-12 Subunit p40

Share to Neoplasms

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 22515181
DOI: 10.3109/08977194.2012.678843

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-12: clinical usage and molecular markers of cancer susceptibility.PMID 22515181Read ↗

Single-nucleotide polymorphisms of the IL-12 gene lead to a higher cancer risk: a meta-analysis based on 22,670 subjects.Semantic proximity Read ↗

IL-12 Family Cytokines: General Characteristics, Pathogenic Microorganisms, Receptors, and Signalling PathwaysSemantic proximity Read ↗

Role of interleukin-12 gene polymorphisms in the onset risk of cancer: a meta-analysis.Semantic proximity Read ↗

Functional polymorphisms in the interleukin-12 gene contribute to cancer risk: evidence from a meta-analysis of 18 case-control studies.Semantic proximity Read ↗

Interaction analysis of IL-12A and IL-12B polymorphisms with the risk of colorectal cancer.Semantic proximity Read ↗

The chemical biology of IL-12 production via the non-canonical NFkB pathwaySemantic proximity Read ↗

The Role of Interleukins in Colorectal Cancer.Semantic proximity Read ↗

Contribution of Interleukin-12A Genotypes to Breast Cancer Risk.Semantic proximity Read ↗

Interleukin-12B+1188A/C polymorphism contributes to increased hepatocellular carcinoma susceptibility: evidence from a meta-analysis.Semantic proximity Read ↗

IL-12 and IL-23—Close Relatives with Structural Homologies but Distinct Immunological FunctionsSemantic proximity Read ↗

Tumor-related interleukins: old validated targets for new anti-cancer drug developmentSemantic proximity Read ↗

Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.